3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia
10
Prostatic Neoplasms
6
Lymphoma
6
Burkitt Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory
2
Prostate Cancer Metastatic
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lipomatosis, Multiple Symmetrical
1
Lipoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Cardiotoxicity
1
Interventions
Hydrocortisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lipomatosis, Multiple Symmetrical
×
Hydrocortisone
×
Clear all
NCT04821583
2021-03-29
N-of-1 SLN
Erasmus Medical Center
Phase 3
Unknown
1 enrolled